Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Cymbalta for Obsessive Compulsive Disorder
NCT00464698Phase 4Completed
- Sponsor
- Massachusetts General Hospital
- Start
- Dec 2005
- Primary completion
- Dec 2013
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of duloxetine in obsessive compulsive disorder (OCD), sponsored by Massachusetts General Hospital. Started Dec 2005; status: completed.
02
Drugs
duloxetine
03
Conditions
obsessive compulsive disorder (OCD)
Beyond the preview
Go deeper on NCT00464698.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00464698.